Journal profile · Medicine-Pharmacology (medical)
Drug and Therapeutics Bulletin
ISSN 0012-6543 · eISSN 1755-5248 · BMJ Publishing Group
Drug and Therapeutics Bulletin: subscription journal; 60 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Drug and Therapeutics Bulletin is published by BMJ Publishing Group. By OpenAlex counts of its recent articles, its largest topics are Pharmacy and Medical Practices, Pharmacovigilance and Adverse Drug Reactions and Pharmaceutical industry and healthcare, together about 27.9% of its articles. Its main subfields are Pharmacology. (generated from OpenAlex topic counts and CAS ranking data)
Drug and Therapeutics Bulletin (DTB) covers practical, independent and evidence-based information on drugs, medication and prescribing. Drug and Therapeutics Bulletin (DTB) publishes independent evaluations and practical advice on individual treatments and the overall management of disease. DTB summarises the best available evidence to enable doctors, pharmacists and other healthcare professionals to make informed and unbiased choices to help patients get the best care. DTB is wholly independent of the pharmaceutical industry, government and regulatory authorities and is also free of advertising and other forms of commercial sponsorship.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Pharmacology (medical)
Editor-in-chief Gordon MallarkeyPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacy and Medical PracticesPharmacology, Toxicology and Pharmaceutics12.8%
- Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics9.3%
- Pharmaceutical industry and healthcarePharmacology, Toxicology and Pharmaceutics5.7%
- Pharmaceutical Practices and Patient OutcomesMedicine5.6%
- Blood Pressure and Hypertension StudiesMedicine5%
- Asthma and respiratory diseasesMedicine4.4%
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance4.3%
- Antibiotics Pharmacokinetics and EfficacyMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pharmacology (medical) | Q4 | 215/278 | 22nd |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.1LetPub ·
- SJR 2026-06
- 0.19LetPub ·
- SNIP 2026-06
- 0.26LetPub ·
- h-index
- 26OpenAlex ·
- i10-index
- 175OpenAlex ·
- 2-year mean citedness
- 0.47OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 3,775 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 42 | 5 | 153 |
| 2025 | 60 | 3 | 264 |
| 2024 | 78 | 1 | 354 |
| 2023 | 76 | 5 | 326 |
| 2022 | 82 | 3 | 323 |
| 2021 | 82 | 5 | 317 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websitePeer review
- Peer review
Independence from pharmaceutical industry, government, regulatory authorities; free of advertising and commercial sponsorship. Model summary
DTB is wholly independent of the pharmaceutical industry, government and regulatory authorities and is also free of advertising and other forms of commercial sponsorship.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BMJ Publishing Group
- ISSN
- 0012-6543
- Electronic ISSN
- 1755-5248
- Official links
- Journal homepage ↗OpenAlex
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Drug and Therapeutics Bulletin
Which databases index Drug and Therapeutics Bulletin?
According to LetPub and DOAJ records, Drug and Therapeutics Bulletin is indexed in Scopus.
Is Drug and Therapeutics Bulletin open access, and what is the APC?
Drug and Therapeutics Bulletin is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .